Live News EQUITY FLASH L impact Oct 15, 2026, 10:54 PM UTC HC Wainwright Maintains Krystal Biotech Price Target at $361 HC Wainwright & Co. maintained its $361.00-per-share price target for Krystal Biotech. KRYS SquawkNews Desk